Published in Allergy Asthma Clin Immunol on December 15, 2008
Bronchial provocation tests in etiologic diagnosis and analysis of asthma. Am Rev Respir Dis (1975) 3.37
Occupational asthma in Europe and other industrialised areas: a population-based study. European Community Respiratory Health Survey Study Group. Lancet (1999) 3.02
Occupational asthma. Am J Respir Crit Care Med (2005) 2.43
Sensitivity and specificity of PC20 and peak expiratory flow rate in cedar asthma. J Allergy Clin Immunol (1990) 2.37
Evidence based guidelines for the prevention, identification, and management of occupational asthma. Occup Environ Med (2005) 2.32
Is the clinical history a satisfactory means of diagnosing occupational asthma? Am Rev Respir Dis (1991) 1.97
Canadian Thoracic Society guidelines for occupational asthma. Can Respir J (1998) 1.80
Occupational asthma in a national disability survey. Chest (1987) 1.65
Assessment of asthma in the workplace. ACCP consensus statement. American College of Chest Physicians. Chest (1995) 1.50
Reported incidence of occupational asthma in France, 1996-99: the ONAP programme. Occup Environ Med (2003) 1.47
Diagnosing occupational asthma: use of induced sputum. Eur Respir J (1999) 1.42
Comparison of serial monitoring of peak expiratory flow and FEV1 in the diagnosis of occupational asthma. Am J Respir Crit Care Med (1998) 1.27
How many times per day should peak expiratory flow rates be assessed when investigating occupational asthma? Thorax (1993) 1.25
Physician based surveillance system for occupational respiratory diseases: the experience of PROPULSE, Québec, Canada. Occup Environ Med (1997) 1.23
Incidence by occupation and industry of acute work related respiratory diseases in the UK, 1992-2001. Occup Environ Med (2005) 1.21
Specific IgE to isocyanates: a useful diagnostic role in occupational asthma. J Allergy Clin Immunol (1998) 1.21
An effective strategy for diagnosing occupational asthma: use of induced sputum. Am J Respir Crit Care Med (2004) 1.19
Occupational asthma: an approach to diagnosis and management. CMAJ (2003) 1.10
Consequences of occupational asthma on employment and financial status: a follow-up study. Eur Respir J (1997) 1.09
Occupational lung disease. 8. The diagnosis of occupational asthma from serial measurements of lung function at and away from work. Thorax (1996) 1.08
Recent developments in diisocyanate asthma. Ann Allergy Asthma Immunol (2003) 1.06
Assessment of impairment/disability due to occupational asthma through a multidimensional approach. Eur Respir J (2006) 1.04
Guidelines for assessing and managing asthma risk at work, school, and recreation. Am J Respir Crit Care Med (2004) 1.03
Relation between occupational asthma case history, bronchial methacholine challenge, and specific challenge test in patients with suspected occupational asthma. Am J Ind Med (1998) 1.02
A systematic review of the diagnosis of occupational asthma. Chest (2007) 1.02
Occurrence of occupational asthma. Chest (1993) 0.97
Occupational asthma: validity of monitoring of peak expiratory flow rates and non-allergic bronchial responsiveness as compared to specific inhalation challenge. Eur Respir J (1992) 0.97
A descriptive study of work aggravated asthma. Occup Environ Med (2004) 0.94
Reactive airways dysfunction syndrome (RADS): guidelines for diagnosis and treatment and insight into likely prognosis. Ann Allergy Asthma Immunol (1999) 0.92
The prognosis of occupational asthma due to detergent enzymes: clinical, immunological and employment outcomes. Clin Exp Allergy (2006) 0.92
Clinical evaluation, management, and prevention of work-related asthma. Am J Ind Med (2000) 0.89
Use of pulmonary function tests in the diagnosis of occupational asthma. Ann Allergy Asthma Immunol (2003) 0.87
Case-by-case assessment of adult-onset asthma attributable to occupational exposures among members of a health maintenance organization. J Occup Environ Med (2006) 0.87
Workplace irritant exposures: do they produce true occupational asthma? Ann Allergy Asthma Immunol (2003) 0.85
Material safety data sheets: are they reliable in identifying human hazards? J Allergy Clin Immunol (2002) 0.81
Persistence of bronchial reactivity to occupational agents after removal from exposure and identification of associated factors. Ann Allergy Asthma Immunol (2003) 0.78
Diagnostic testing in occupational asthma. Ann Allergy Asthma Immunol (1999) 0.77
An approach to the diagnosis of occupational asthma. Ann Allergy Asthma Immunol (1999) 0.77
Tiotropium bromide step-up therapy for adults with uncontrolled asthma. N Engl J Med (2010) 6.19
2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema. Allergy Asthma Clin Immunol (2010) 2.75
Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema. N Engl J Med (2010) 2.28
American Academy of Allergy, Asthma & Immunology Work Group report: exercise-induced asthma. J Allergy Clin Immunol (2007) 1.89
The diagnosis and management of acute and chronic urticaria: 2014 update. J Allergy Clin Immunol (2014) 1.75
HAE international home therapy consensus document. Allergy Asthma Clin Immunol (2010) 1.42
Randomized placebo-controlled trial of the bradykinin B₂ receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial. Ann Allergy Asthma Immunol (2011) 1.28
A focused parameter update: hereditary angioedema, acquired C1 inhibitor deficiency, and angiotensin-converting enzyme inhibitor-associated angioedema. J Allergy Clin Immunol (2013) 1.18
Assessment of hereditary angioedema treatment risks. Allergy Asthma Proc (2013) 1.04
Sleep and allergic disease: a summary of the literature and future directions for research. J Allergy Clin Immunol (2012) 0.92
Poor sleep and daytime somnolence in allergic rhinitis: significance of nasal congestion. Am J Respir Med (2002) 0.91
The relationship between insect sting allergy treatment and patient anxiety and depression. Allergy Asthma Proc (2014) 0.84
Hereditary angioedema with a focus on the child. Allergy Asthma Proc (2015) 0.83
Differential expression of microRNAs in exhaled breath condensates of patients with asthma, patients with chronic obstructive pulmonary disease, and healthy adults. J Allergy Clin Immunol (2013) 0.82
Rhinitis and sleep. Sleep Med Rev (2011) 0.81
A comparison of intranasal corticosteroid, leukotriene receptor antagonist, and topical antihistamine in reducing symptoms of perennial allergic rhinitis as assessed through the Rhinitis Severity Score. Allergy Asthma Proc (2010) 0.81
The Allergies, Immunotherapy, and RhinoconjunctivitiS (AIRS) survey: provider practices and beliefs about allergen immunotherapy. Int Forum Allergy Rhinol (2014) 0.81
Predictors of response to tiotropium versus salmeterol in asthmatic adults. J Allergy Clin Immunol (2013) 0.80
The effect of intranasal steroid budesonide on the congestion-related sleep disturbance and daytime somnolence in patients with perennial allergic rhinitis. Allergy Asthma Proc (2005) 0.80
Rectal motion in patients receiving preoperative radiotherapy for carcinoma of the rectum. Int J Radiat Oncol Biol Phys (2011) 0.79
Cinryze as the first approved C1 inhibitor in the USA for the treatment of hereditary angioedema: approval, efficacy and safety. J Blood Med (2010) 0.78
The elite athlete: yes, with allergy we can. J Allergy Clin Immunol (2008) 0.78
Effects of poor sleep in allergic rhinitis. Curr Opin Allergy Clin Immunol (2005) 0.78
N-acetylaspartate metabolism in neural cells. Adv Exp Med Biol (2006) 0.77
Recombinant human C1 esterase inhibitor for the treatment of hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE). Expert Rev Clin Immunol (2015) 0.76
Efficacy and safety of an intravenous C1-inhibitor concentrate for long-term prophylaxis in hereditary angioedema. Allergy Rhinol (Providence) (2017) 0.75
A comparison of intranasal corticosteroid, leukotriene receptor antagonist, and topical antihistamine in reducing symptoms of perennial allergic rhinitis as assessed through the Rhinitis Severity Score. Allergy Rhinol (Providence) (2010) 0.75
Chronic cough: an interactive case discussion. Allergy Asthma Proc (2006) 0.75
Anxiety and depression in adults with primary immunodeficiency: How much do these patients experience and how much do they attribute to their primary immunodeficiency? Allergy Asthma Proc (2016) 0.75
Recurrent septic shock in a 34-year-old woman. Allergy Asthma Proc (2012) 0.75
Icatibant for Multiple Hereditary Angioedema Attacks across the Controlled and Open-Label Extension Phases of FAST-3. Int Arch Allergy Immunol (2015) 0.75
Multiple doses of icatibant used during pregnancy. Allergy Rhinol (Providence) (2017) 0.75
Reliability of skin test results when read at different time points. Allergy Asthma Proc (2011) 0.75
The perceived obstacles in performing patch test to detect allergic contact dermatitis: a comparison between community allergists and directors of allergy training programs. Ann Allergy Asthma Immunol (2008) 0.75
A 73-year-old woman with persistent diarrhea and onychomycosis. Allergy Asthma Proc (2016) 0.75